Political pressure and persistently high interest rates have some wondering if the industry’s model is broken.

Weeks after ordering all Food and Drug Administration employees back into the office, the agency is allowing some of its most ...

As the Trump administration continues to gut federal health agencies, several professional health and advocacy groups ar | ...

Experts say the layoffs are already causing issues in drug development — and things may get far worse without critical ...

Biotech leaders urge Senate intervention as FDA restructuring risks expertise loss impacting operations. Read more here.

A former top FDA official said it’s only a matter of time before the chaos at the agency starts to impact drug reviews.

The number of employees laid off dropped year over year during the first quarter. BioSpace recaps the five largest layoffs, ...

A FDA generic drug office was eliminated — and the implications will be felt not only by drugmakers, but consumers ...

Layoffs at the Food and Drug Administration are expected to reduce the FDA's workforce by 20%. Here & Now 's Scott Tong talks ...

U.S. Food and Drug Administration approvals of life-changing, high-risk medical devices reportedly slowed to a 10-year low ...